Phenoia B.
About Phenoia B.
Phenoia B. is a Global Clinical Trial Manager at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in oncology clinical trials and a strong background in data analysis.
Current Role at Bristol Myers Squibb
Phenoia B. holds the position of Global Clinical Trial Manager at Bristol Myers Squibb, located in Summit, New Jersey, United States. In this role, she plays a crucial part in the successful implementation of multiple clinical trials, ensuring compliance with regulatory standards. Her expertise significantly contributes to advancements in oncology clinical trials, aiding in the development of effective cancer treatments.
Previous Experience at Elligo Health Research
Before joining Bristol Myers Squibb, Phenoia B. worked as a Study Manager at Elligo Health Research from 2019 to 2020, based in New York, New York. During her tenure, she managed clinical studies, gaining valuable experience in coordinating various research projects.
Extensive Career in Clinical Research
Phenoia B. has an extensive career history in clinical research, having served as a Clinical Research Coordinator at multiple institutions including MANHATTAN HEMATOLOGY ONCOLOGY ASSOCIATES, P.C. (2015-2019), Clinilabs (2014-2017), and Clinical Research Solutions (2013-2014). She also worked at the Mount Sinai Beth Israel as a Project Research Assistant from 2011 to 2013 and at Mount Sinai Health System as a Clinical Research Coordinator from 2008 to 2011. Her work in these roles has provided her with a well-rounded perspective on both academic and industry clinical research settings.
Educational Background in Healthcare
Phenoia B. has a solid educational foundation in healthcare. She studied Health/Health Care Administration/Management at Monroe College, where she achieved a Master of Business Administration (M.B.A.). Additionally, she completed her Licensed Practical/Vocational Nurse Training at Union County College between 2014 and 2017.
Expertise in Data Analysis and IRB Processes
Phenoia B. is well-versed in data analysis, which has been pivotal in optimizing clinical trial outcomes. Furthermore, she has been actively involved in Institutional Review Board (IRB) processes, playing a key role in ensuring that ethical standards are maintained in clinical research. Her analytical skills and commitment to ethical practices make her a valuable asset in her field.